Try for free
Redline Fridays

FDA Guidance for Cybersecurity in Medical Devices

We analyzed the updated FDA Cybersecurity guidance.

Alexis Bartouilh de Taillac
Written by Alexis Bartouilh de TaillacPublished on February 13, 2026
FDA Guidance for Cybersecurity in Medical Devices

Redlining Fridays - Every Friday, we share a new redlined guidance or standard

We analyzed the updated FDA Cybersecurity guidance to see what actually changed, since this is the third version in as many years.

Short answer: Not much text, but the biggest shift is in the framing.

The FDA now explicitly frames cybersecurity as a Quality Management System responsibility. It's no longer a side topic, it must be part of design controls, risk management, and post-market surveillance. Same level as any other safety requirement.

The most visible change is that the guidance swaps every mention of "QSR" for "QMSR" (the new regulation that went into effect February 2026). The true shift is the FDA saying: if your cybersecurity strategy isn't woven into your QMS documentation, you're not compliant.

Our take: This clarifies expectations. Cybersecurity used to live in a gray zone between engineering, IT, and regulatory, and now it's straightforward: show us where it sits in your QMS.

Which guidance should we tackle next?